Skip to content

Author

Anjali Anil

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Novel Therapeutics and Antifungal Agents

Next-generation azoles, such as oteseconazole and VT-1598, offer improved specificity for fungal sterol 14α-demethylase (CYP51) while reducing host toxicity, and new echinocandin derivatives, such as rezafungin, exhibit improved pharmacokinetics, enabling less frequent dosing.

Anjali Anil, A. Chakrabarti, Shivaprakash Mandya Rudramurthy · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.